Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine. (2011). Drugs and Therapy Studies, 2(1), e1. https://doi.org/10.4081/dts.2012.e1